Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 513
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00643877 | Trial of Preoperative Hepatic and Regional Arterial Chemotherapy (PHRAC) to Prevent Postoperative Liver Metastasis of Colorectal Cancer | ||
| NCT04220528 | Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC | ||
| NCT06639399 | Effect of Different Acupuncture Schemes for Postoperative Urinary Retention in Cervical Cancer Patients | ||
| NCT02518191 | Effects of GnRHa on Ovarian Function Against Chemotherapy-induced-gonadotoxicity | ||
| NCT04669496 | Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors | ||
| NCT04421469 | Triprilimab(JS001) and Chemotherapy Combined With Local Treatment for Multiple Metastatic NPC | ||
| NCT06836869 | Modified Tumor-free Techniques Operation to Cervical Cancer | ||
| NCT05198154 | ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC | ||
| NCT06200051 | Multi-cancer Joint Screening and Early Diagnosis and Treatment Project Based on the Combination of Chinese Traditional and Western Medicine in Lanxi City | ||
| NCT06741020 | Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma | ||
| NCT01926483 | Phase II Trial of Regimen for Stage III (N2) NSCLC Using Induction Treatment Followed by Resection | ||
| NCT07111429 | Chinese Ostomy Collaboration Group (COCG) Clinical Study -SITI Classification | ||
| NCT05234905 | H101 Combined With Camrelizumab for Recurrent Cervical Cancer | ||
| NCT06586801 | The Patient-Reported Outcomes in ALK Positive Advanced NSCLC in China | ||
| NCT03567629 | Evaluate the Efficacy of Irinotecan Versus Oxaliplatin in the First-line Treatment of Refractory Metastatic Colorectal Cancer | ||
| NCT05148767 | UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer | ||
| NCT03940001 | A Study of Sintilimab Plus Chemoradiation Before Surgery for Esophageal Cancer | ||
| NCT06839157 | Artificial Intelligence - Assisted Model for Optimal Timing of Surgery in Advanced Ovarian Cancer | ||
| NCT06349044 | A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies. | ||
| NCT05564897 | Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder Cancer | ||
| NCT06968091 | Effect of Trendelenburg Positioning on Anesthesia-Induced Hypotension in Elderly Patients | ||
| NCT06886347 | Metastatic Nasopharyngeal Carcinoma | ||
| NCT04447326 | Toripalimab, Endostar Combined With Radiotherapy and Chemotherapy for Nasopharyngeal Carcinoma | ||
| NCT04093375 | Radical Prostatectomy Versus Radical Radiotherapy for Locally Advanced Prostate Cancer | ||
| NCT06530719 | A Study to Evaluate the Efficacy of Osimertinib in Patients With EGFR-sensitive Mutated Non-small Cell Lung Cancer Progression After Receiving Adjuvant Targeted Therapy Following Radical Surgery | ||
| NCT07325630 | Perioprative Study of IBI363 in Patients With MHC-II-Negative Locally Advanced Gastric Cancer | ||
| NCT06832228 | Study of Pomalidomide Combination with Rituximab and Anti-PD-1 Antibody （PPR） in Third or Later Line Therapy of DLBCL | ||
| NCT05242861 | Retrospective Study of Brachytherapy | ||
| NCT04910594 | Clinical Study the Efficacy and Safety of Rh-EPO in the Treatment of Anemia in Lymphoma | ||
| NCT03829553 | Hypofractionated Irradiation At Regional Nodal Area for Breast Cancer Vs Existed Standard Treatment | ||
| NCT02752360 | Biodegradable Stenting Anastomoses Versus Double-layer Hand Sutures for Reconstruction in Intestinal Anastomosis | ||
| NCT07326150 | Construction of a Predictive Model for the Efficacy of Chemoprevention Combined With Targeted Therapy in Pancreatic Cancer | ||
| NCT04974346 | Para-aortic Prophylactic Irradiation for Locally Advanced Cervical Cancer | ||
| NCT05544149 | TRT for ES-SCLC After First Line Treatment With Immune Checkpoint Inhibitors | ||
| NCT07065435 | RC48 Plus Bevacizumab or Pyrotinib in HER2-Positive Metastatic Breast Cancer After T-DXd Failure: A Phase II Study | ||
| NCT01463501 | Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal Cancer | ||
| NCT04527861 | Oncologic Outcomes of Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer | ||
| NCT02772705 | Comparison of SUV Using SPECT/CT Between Grave's Disease Patients and Normal Humans | ||
| NCT05928312 | Fruquintinib Combined With Chemotherapy as Third-line /Third-line+ Treatment in Advanced Colorectal Cancer | ||
| NCT02681822 | Multi-center Imaging Genetics Studies in China | ||
| NCT07029464 | Comparison of Short- and Long-term Outcomes Between Robotic and Laparoscopic Hemicolectomy of Right Colon Cancer : A Multicenter Propensity Score Matching Analysis | ||
| NCT03726736 | Anlotinib Combined With Docetaxel Versus Docetaxel for Previous Treated Advanced NSCLC | ||
| NCT03313271 | China Lymphoma Patient Registry Study | ||
| NCT01175447 | S-1 and Radiotherapy in Elderly Patients With Esophageal Cancer | ||
| NCT06253078 | Ciprofol EC50 for Inducing Loss of Consciousness in Elderly Patients | ||
| NCT06437678 | Phase II Study of Liposomal Irinotecan for Advanced Refractory Gastric Cancer | ||
| NCT03317483 | DEB-TACE Treatment in 367 Liver Cancer Patients | ||
| NCT00827307 | Zoladex Plus Tamoxifen in Breast Cancer | ||
| NCT05903456 | Icaritin Soft Capsule Combined With Lenvatinib and TACE for the Treatment of Hepatocellular Carcinoma | ||
| NCT06481956 | T-DM1 Combined With CDK4/6 Inhibitor Ribociclib |
